On the other hand, either alone or even when combined, these biomarkers failed to overperform with respect to the “classical” biomarker CA-125, which remains the gold standard in terms of accuracy for diagnosing ovarian cancer. This evidence concerns the gene MUC16 and ovarian cancer.